Avid Bioservices Inc (CDMO)

[jakedogman1]

EAM Global w/ $2.3 bil AUM focuses on small/micro cap value opportunities for institutional investors.

Tappan and Bandera also focused on small cap undervalued. Expect rev ramp showing up FY 19. Lias basically said they are busy but results won't show up until FY 19 in ASM presentation. Lots of retail to shake out in the meantime. EAM did not buy $500 k w/o kicking tires. All imo.

http://eaminvestors.com/